CPRX

25.85

1.30% -0.34

시간 외 거래: 25.76 -0.09 -0.35%

Catalyst Pharmaceuticals Inc (CPRX)

개요 뉴스 가격 이력 옵션 체인 Financials CPRX 왜 하락? 토론 예측

전일 마감가:

$26.19

열려 있는:

$26.11

하루 거래량:

879.79K

Relative Volume:

0.72

시가총액:

$3.16B

수익:

$588.99M

순이익/손실:

$214.33M

주가수익비율:

15.35

EPS:

1.6844

순현금흐름:

$208.61M

1주 성능:

+2.13%

1개월 성능:

+11.28%

6개월 성능:

+21.59%

1년 성능:

+11.28%

1일 변동 폭

$25.60

$26.20

1주일 범위

$24.69

$26.45

52주 변동 폭

$19.05

$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

명칭

Catalyst Pharmaceuticals Inc

부문

Healthcare (1112)

산업

Biotechnology (621)

전화

(305) 529-2522

주소

355 ALHAMBRA CIRCLE, CORAL GABLES

직원

182

트위터

@CatalystForRare

다음 수익 날짜

2024-11-06

최신 SEC 제출 서류

CPRX's Discussions on Twitter

Compare CPRX vs VRTX, REGN, ARGX, ALNY, ONC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
CPRX Catalyst Pharmaceuticals Inc	25.85	3.20B	588.99M	214.33M	208.61M	1.6844
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-02-04	개시	Robert W. Baird	Outperform
2024-11-18	개시	Stephens	Overweight
2024-03-14	개시	Citigroup	Buy
2024-03-07	개시	BofA Securities	Buy
2023-12-21	개시	Oppenheimer	Outperform
2022-08-24	다운그레이드	ROTH Capital	Buy → Neutral
2018-09-21	개시	Cantor Fitzgerald	Overweight
2018-09-07	재개	Piper Jaffray	Overweight
2016-10-05	업그레이드	Piper Jaffray	Neutral → Overweight
2016-04-26	다운그레이드	Piper Jaffray	Overweight → Neutral
2014-09-30	재확인	ROTH Capital	Buy
2014-09-16	재확인	ROTH Capital	Buy
2014-09-15	재확인	H.C. Wainwright	Buy
2013-10-21	재확인	Aegis Capital	Buy
2013-09-24	개시	Maxim Group	Buy
2013-09-06	재확인	Aegis Capital	Buy
2013-04-18	개시	Aegis Capital	Buy
2012-08-27	업그레이드	Rodman & Renshaw	Mkt Perform → Mkt Outperform
2009-10-01	업그레이드	Merriman	Sell → Neutral
2009-05-29	다운그레이드	Hapoalim	Neutral → Underperform
2009-05-29	다운그레이드	Merriman Curhan Ford	Buy → Sell
2008-12-15	개시	Merriman Curhan Ford	Buy
2007-11-28	개시	Rodman & Renshaw	Mkt Outperform
2007-01-31	개시	Stifel Nicolaus	Buy
2007-01-05	개시	First Albany	Buy

모두보기

Catalyst Pharmaceuticals Inc 주식(CPRX)의 최신 뉴스

07:33 AM

See How Institutions Boost Catalyst Shares - Yahoo Finance Australia

07:33 AM

Apr 14, 2026

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 14, 2026

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Strength - Yahoo Finance

Apr 14, 2026

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX): A Strong Growth Stock with a Positive Technical Setup - ChartMill

Apr 14, 2026

Apr 13, 2026

Gains Recap: Is Catalyst Pharmaceuticals Incs growth already priced inMarket Trend Report & Verified Technical Signals - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Jim Cramer on Catalyst Pharmaceuticals: "It's a very inexpensive stock" - MSN

Apr 12, 2026

Apr 10, 2026

If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now - qz.com

Apr 10, 2026

Catalyst Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 10, 2026

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200 - TradingView — Track All Markets

Apr 10, 2026

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Emerges as a Top Affordable Growth Stock - ChartMill

Apr 10, 2026

Apr 09, 2026

Price Action: Will Catalyst Pharmaceuticals Inc benefit from government policy2026 Trading Volume Trends & Reliable Price Breakout Signals - baoquankhu1.vn

Apr 09, 2026

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know - TradingView — Track All Markets

Apr 09, 2026

(CPRX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Apr 09, 2026

Apr 08, 2026

Catalyst Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 08, 2026

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum - Sahm

Apr 08, 2026

Apr 07, 2026

Bear Alert: Is Catalyst Pharmaceuticals Inc currently under institutional pressure2026 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Apr 07, 2026

Catalyst Pharmaceuticals (CPRX) Is Up 5.0% After Extending Firdapse Exclusivity And Launching AgamreeHas The Bull Case Changed? - Yahoo Finance

Apr 07, 2026

Apr 06, 2026

Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics, and Avalo Therapeutics - Bitget

Apr 06, 2026

IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints - TradingView — Track All Markets

Apr 06, 2026